Sanofi Pasteur MSD
Mallards Reach, Bridge Avenue
Maidenhead
SL6 1QP
United Kingdom
Tel: 44-1628-785-291
Fax: 44-1628-671-722
Website: http://www.aventis-pasteur-msd.com/
10 articles about Sanofi Pasteur MSD
-
Sanofi Pasteur MSD: The Four-Type HPV Vaccine Gardasil(R) Demonstrates Real Life Benefits
5/8/2009
-
Sanofi Pasteur MSD Release: New Results Confirm That Young Women Up To The Age Of 26 Years Can Benefit From Vaccination With Gardasil(R)
2/17/2009
-
Sanofi Pasteur MSD Release: Gardasil(R) Vaccine Honoured with International Galien Prize for Pharmaceutical Research
10/31/2008
-
Sanofi Pasteur MSD Announces Cross-Protective Effect and Prevention of Precancerous Vaginal Lesions Added to Product Information of Gardasil(R)
9/12/2008
-
Sanofi Pasteur MSD Release: Sustained High Efficacy of Gardasil(R) Against Early Cervical Lesions, Precancerous Vulvar and Vaginal Lesions, and Genital Warts in Longest Follow-up of Large Phase III Studies
3/7/2008
-
Sanofi Pasteur MSD Welcomes Sweden's Decision to Recommend and Fund Human Papillomavirus Vaccination for School Girls
2/27/2008
-
Sanofi Pasteur MSD Applies for European Approval of the First Seasonal Influenza Vaccine Delivered by Intradermal Microinjection
2/13/2008
-
Sanofi Pasteur MSD Launches New Website
5/21/2007
-
Federal Advisers Endorse 5-In-1 Vaccine
1/26/2007
-
Sanofi Pasteur MSD's Gardasil Receives Positive Opinion From European Medicine Agency
7/28/2006